What Is Methylphenidate Withdrawal?
Methylphenidate hydrochloride tablet is a western medicine preparation mainly used for attention deficit hyperactivity disorder and other diseases.
Methylphenidate hydrochloride
- Chinese name
- Methylphenidate hydrochloride
- Foreign name
- MethylphenidateHydrochlorideTablets
- Shape
- White film
- Adverse reactions
- Insomnia, dizziness, dizziness, headache, nausea
- Methylphenidate hydrochloride tablet is a western medicine preparation mainly used for attention deficit hyperactivity disorder and other diseases.
- Methylphenidate hydrochloride
- Common name: methylphenidate hydrochloride tablets English name: MethylphenidateHydrochlorideTablets The main ingredient of this product is methylphenidate hydrochloride, and its chemical name is -phenyl-2-piperidine acetate methyl chloride hydrochloride. Molecular formula: C14H19NO2? HCl Properties: This product is a white tablet.
- Methylphenidate-Ritalin is a respiratory stimulant, which excites the respiratory center through the carotid body chemoreceptors in small doses, and directly excites the medullary respiratory center in large amounts.
- Methylphenidate-Ritalin is easily absorbed orally. The effect of one administration can be maintained for about 4 hours. It is rapidly metabolized in the body and excreted by the kidneys.
- For attention deficit hyperactivity disorder (children's hyperactivity disorder, mild brain dysfunction), narcolepsy, and coma caused by excessive inhibitory drugs such as barbiturates and chloral hydrate.
- Adults take 10 mg once a day, 2 to 3 times a day, 45 minutes before meals. Children over 6 years old take 5mg once a day, twice a day before breakfast or lunch; then increase by 5 to 10mg per week as needed, and methylphenidate-ritalin does not exceed 40mg a day.
- Insomnia, dizziness, dizziness, headache, nausea, anorexia, palpitations and other contraindications glaucoma, agitated depression, hyperexcitation, and allergies to this product.
- Use with caution in patients with epilepsy and hypertension. Those taking monoamine oxidase inhibitors should use this product after 2 weeks of withdrawal. It is not advisable to take medicine after evening to avoid causing insomnia. This product can cause dependence. Medication for children: There have been reports that this product can inhibit growth and development. Children should be cautious in long-term medication. Children under 6 years of age should be avoided. Use of this product can inhibit growth and development. Children should be cautious in long-term medication. Methylphenidate-Ritalin was used. In elderly patients, methylphenidate-ritalin is started in small doses, and the dosage should be reduced as appropriate.
- 1. The combination of methylphenidate-ritalin with antiepileptic drugs, anticoagulants, and bataxone can increase the blood concentration and cause toxic reactions. 2, methylphenidate-ritalin combined with antihypertensive drugs and diuretic antihypertensive drugs, the effect is weakened. 3. Methylphenidate-Ritalin can be used in combination with anti-M-choline drugs. 4. Methylphenidate-Ritalin is used in combination with central stimulants and epinephrine receptor agonists. The combined effects can induce tension, agitation, insomnia, and even convulsions or arrhythmias.
- Symptoms of poisoning: When methylphenidate-Ritalin is overdose, there are psychiatric symptoms such as anxiety, tension, confusion, delirium, hallucinations, and severe cases may appear coma, convulsions and even death. Treatment: gastric lavage, promotion of excretion, and appropriate symptomatic treatment and supportive therapy depending on the condition. Specifications: 10mg storage: shading, sealed and stored.